Thales S.A. reported strong first-half 2026 results driven by accelerating growth in its defense segment, which saw double-digit order growth and margin expansion to 13.8%. Aerospace profitability improved, and the company generated exceptional free cash flow. However, the Cyber & Digital division faced margin contraction and pricing pressures, though cyber sales showed signs of recovery in the second quarter. The company’s strong order book and improved margins support a positive outlook with a 19% upside potential, maintaining a buy rating.
Inhibrx Biosciences CEO Lappe Mark purchased 5,895 shares at $99.29 each following positive Phase 2 trial results for their cancer drug INBRX-106 combined with Keytruda. The trial showed a 48.3% tumor response rate, nearly double that of Keytruda alo...
Chewy will report its Q2 2026 earnings on September 9, with analysts expecting earnings per share (EPS) of $0.36, a 9.1% increase year-over-year, and revenue of $3.32 billion, up 6.8%. Growth is driven by its Autoship subscription program and expansi...
Tarsus Pharmaceuticals recently acquired Alkeus Pharmaceuticals, gaining worldwide rights to gildeuretinol, a promising Phase 3 drug for Stargardt's disease, which currently lacks FDA-approved treatments. Analyst Jefferies raised Tarsus' price target...
The Trade Desk is undergoing restructuring with a 15% workforce reduction costing up to $51 million, following its removal from the S&P 500 index which caused a 2% stock drop. Despite these challenges, the company shows strong financial health, repor...
GameStop reported Q2 2026 revenue of $790.20 million, beating analyst estimates but showing a 19% year-over-year decline due to a strong prior year and strategic store closures. The company's Collectibles segment grew 57% to $356.30 million, offsetti...
